HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study
- PMID: 24965676
- PMCID: PMC4127184
- DOI: 10.1007/s10461-014-0839-3
HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study
Abstract
Oral pre-exposure prophylaxis (PrEP) can reduce HIV incidence among at-risk persons. However, for PrEP to have an impact in decreasing HIV incidence, clinicians will need to be willing to prescribe PrEP. HIV specialists are experienced in using antiretroviral medications, and could readily provide PrEP, but may not care for HIV-uninfected patients. Six focus groups with 39 Boston area HIV care providers were conducted (May-June 2012) to assess perceived barriers and facilitators to prescribing PrEP. Participants articulated logistical and theoretical barriers, such as concerns about PrEP effectiveness in real-world settings, potential unintended consequences (e.g., risk disinhibition and medication toxicity), and a belief that PrEP provision would be more feasible in primary care clinics. They identified several facilitators to prescribing PrEP, including patient motivation and normative guidelines. Overall, participants reported limited prescribing intentions. Without interventions to address HIV providers' concerns, implementation of PrEP in HIV clinics may be limited.
Similar articles
-
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28. AIDS Patient Care STDS. 2020. PMID: 32109141 Free PMC article.
-
"Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation.AIDS Patient Care STDS. 2017 Apr;31(4):196-204. doi: 10.1089/apc.2017.0002. AIDS Patient Care STDS. 2017. PMID: 28414261 Free PMC article.
-
Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.AIDS Patient Care STDS. 2016 Jul;30(7):339-48. doi: 10.1089/apc.2016.0048. AIDS Patient Care STDS. 2016. PMID: 27410497 Free PMC article.
-
Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.J Gen Intern Med. 2017 Feb;32(2):192-198. doi: 10.1007/s11606-016-3899-4. Epub 2016 Oct 19. J Gen Intern Med. 2017. PMID: 27761767 Free PMC article. Review.
-
Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.Adv Ther. 2020 May;37(5):1778-1811. doi: 10.1007/s12325-020-01295-0. Epub 2020 Mar 30. Adv Ther. 2020. PMID: 32232664 Free PMC article. Review.
Cited by
-
A qualitative study identifying implementation strategies using the i-PARIHS framework to increase access to pre-exposure prophylaxis at federally qualified health centers in Mississippi.Implement Sci Commun. 2024 Aug 28;5(1):92. doi: 10.1186/s43058-024-00632-6. Implement Sci Commun. 2024. PMID: 39198914 Free PMC article.
-
The Association between Social Support and Pre-Exposure Prophylaxis use among Sexual Minority Men in the United States: A Scoping Literature Review.AIDS Behav. 2024 Jul 23. doi: 10.1007/s10461-024-04446-4. Online ahead of print. AIDS Behav. 2024. PMID: 39039399 Review.
-
Applying a Three-Tier Approach to Address Gaps in Oral Pre-Exposure Prophylaxis Uptake and Continuity in Uganda: A Mixed Methods Approach.Glob Health Sci Pract. 2024 Apr 29;12(2):e2300229. doi: 10.9745/GHSP-D-23-00229. Print 2024 Apr 29. Glob Health Sci Pract. 2024. PMID: 38467398 Free PMC article.
-
Barriers and Facilitators to Long-Acting Injectable HIV Pre-Exposure Prophylaxis Implementation in Primary Care Since Its Approval in the United States.J Acquir Immune Defic Syndr. 2024 Apr 1;95(4):370-376. doi: 10.1097/QAI.0000000000003370. J Acquir Immune Defic Syndr. 2024. PMID: 38133586
-
Overcoming structural barriers to diffusion of HIV pre-exposure prophylaxis.J Med Access. 2023 Dec 6;7:27550834231214958. doi: 10.1177/27550834231214958. eCollection 2023 Jan-Dec. J Med Access. 2023. PMID: 38075520 Free PMC article. Review.
References
-
- Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34. - PubMed
-
- Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous